South Africa Launches Long-Acting HIV Prevention Shot Amid Growing Demand and Limited Supply
On Friday, June 5 2026, South Africa rolled out a new twice‑yearly injectable HIV prevention drug, lenacapavir, in a high‑profile ceremony that underscored the country’s relentless bat...
Read story →